Franklin Biotechnology Discv A(acc)SGD |
Growth Of 1000 (EUR) | 30/04/2024 |
|
Annual Returns (EUR) | 30/04/2024 | |||||||
2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 30/04 | |
Total Return | 2.57 | -12.14 | 36.00 | 16.88 | -10.98 | -6.96 | 13.52 | 7.59 |
+/- Category | -3.49 | -3.16 | 8.68 | -2.37 | -7.96 | 5.82 | 12.44 | 9.89 |
+/- Category Index | -8.19 | -9.21 | 12.37 | -8.96 | -17.91 | -3.93 | 3.62 | -0.41 |
% Rank in Category | 74 | 81 | 15 | 30 | 77 | 51 | 12 | 4 |
Trailing Returns (EUR) | 03/05/2024 | ||
Total Returns | +/- Category | +/- Category Index | |
1 Day | 0.65 | -0.29 | 1.56 |
1 Week | 4.53 | -0.84 | 3.74 |
1 Month | 0.22 | 0.92 | 0.50 |
3 Months | 2.03 | 0.25 | -2.46 |
6 Months | 27.11 | 9.58 | 11.83 |
YTD | 10.86 | 9.44 | 2.93 |
1 Year | 23.18 | 15.36 | 7.20 |
3 Years Annualised | 2.65 | 6.83 | -4.91 |
5 Years Annualised | 7.39 | 0.94 | -4.52 |
10 Years Annualised | 8.71 | -0.44 | -2.48 |
Category: Sector Equity Biotechnology | |||
Category Index: Morningstar Gbl Biotechnology NR USD |
Quarterly Returns (EUR) | 30/04/2024 | |||
Quarter 1 | Quarter 2 | Quarter 3 | Quarter 4 | |
2024 | 14.49 | - | - | - |
2023 | -0.91 | 0.75 | 1.55 | 11.96 |
2022 | -6.94 | -6.15 | 8.58 | -1.89 |
2021 | -0.88 | -0.49 | -2.86 | -7.09 |
2020 | -11.28 | 25.84 | -1.07 | 5.82 |
2019 | 21.07 | 2.08 | -10.75 | 23.30 |
Advertisement |